Dong-A ST Co., Ltd. (KRX:170900)

Market Cap	423.13B -4.8%
Revenue (ttm)	770.63B +10.0%
Net Income	-514.77M
EPS	-39.78
Shares Out	9.62M
PE Ratio	n/a
Forward PE	11.14
Dividend	653.59 (1.49%)
Ex-Dividend Date	Mar 10, 2026

Volume	10,084
Average Volume	32,287
Open	44,000
Previous Close	43,850
Day's Range	43,950 - 44,550
52-Week Range	38,952 - 56,381
Beta	0.45
RSI	35.04
Earnings Date	Apr 29, 2026

About Dong-A ST

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation; Growtropin II inj./AQ /cartridge to treat growth failure due to an inad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 1,679
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 170900